Erosive Esophagitis: Developing Drugs for Treatment

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program

Unapproved New Drugs/Misbranded/Botox

CGMP/Finished Pharmaceuticals/Adulterated

In May 2025, Medtronic issued a voluntary recall notification to global customers related to specific Newport™ HT70 and HT70 Plus ventilators and certain related Newport™ service parts. The FDA recently designated this voluntary action by Medtronic as a Class I recall.
With this recall, Medtronic i

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Public Engagement Staff.

FDA awards a 5-year grant to the University of Maryland and the University of Michigan to establish a Center for Research on Complex Generics (CRCG).